Lexicon Pharmaceuticals, Inc. (LXRX) vs Sana Biotechnology, Inc. (SANA)
- Lexicon Pharmaceuticals, Inc. LXRX 1.52 −7.88%
- Sana Biotechnology, Inc. SANA 2.27 −8.47%
Lexicon Pharmaceuticals, Inc. and Sana Biotechnology, Inc. are both Biotechnology companies. Lexicon Pharmaceuticals, Inc. and Sana Biotechnology, Inc. are of similar size ($740.9M and $734.2M). Sana Biotechnology, Inc. has the higher net margin (0.00% vs −147.4%) and the higher return on invested capital (0.00% vs −96.4%). Across the 14 metrics below, Lexicon Pharmaceuticals, Inc. leads on 8 and Sana Biotechnology, Inc. on 6.
Valuation
Profitability
| Metric | LXRX | SANA | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.14% | 0.00% | 65.16% |
| Operating margin | (131.43%) | 0.00% | 0.00% |
| Net margin | (147.38%) | 0.00% | 0.00% |
| Free cash flow margin | (156.71%) | 0.00% | 0.00% |
| Return on equity | (40.21%) | (152.87%) | (56.36%) |
| Return on assets | (25.70%) | (53.41%) | (48.04%) |
| Return on invested capital | (96.36%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack